CGTX
CGTX
NASDAQ · Pharmaceuticals

Cognition Therapeutics Inc

$1.07
-0.01 (-0.93%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +2,793.5% upside
Low Target $22.83
Average Target $30.96
High Target $36.58
Current Price $1.07
Current
$1.07
Target
$30.96
$22.83 $30.96 avg $36.58
Scenario Analysis
Bear Case
$22.83
2,033.6%
Low target
Base Case
$30.96
+2,793.5%
Avg target
Bull Case
$36.58
+3,318.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.83
-72.1% from high
52-Week Low
$0.22
+381.3% from low
Target vs 52W High
$30.96
+708.4% vs high
Next Earnings Report
Mar 26, 2026 · Before Market Open
Today
EPS Est: $-0.09
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%